E2F8 and cholangiocarcinoma: This association was corroborated by analyses of public datasets, including NCI60, CCLE, GDSC, and the TCGA cholangiocarcinoma cohort [35, 36], reinforcing the clinical and biological relevance of the E2F8-RRM2 axis (Fig. 3F-G).